HomeCompareCRMK vs JNJ

CRMK vs JNJ: Dividend Comparison 2026

CRMK yields 37037.04% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRMK wins by $2.4065325904961905e+22M in total portfolio value
10 years
CRMK
CRMK
● Live price
37037.04%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.4065325904961905e+22M
Annual income
$23,938,182,827,095,612,000,000,000,000.00
Full CRMK calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CRMK vs JNJ

📍 CRMK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRMKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRMK + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRMK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRMK
Annual income on $10K today (after 15% tax)
$3,148,148.15/yr
After 10yr DRIP, annual income (after tax)
$20,347,455,403,031,270,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CRMK beats the other by $20,347,455,403,031,270,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRMK + JNJ for your $10,000?

CRMK: 50%JNJ: 50%
100% JNJ50/50100% CRMK
Portfolio after 10yr
$1.2032662952480952e+22M
Annual income
$11,969,091,413,547,806,000,000,000,000.00/yr
Blended yield
99.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CRMK
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRMK buys
0
JNJ buys
0
No recent congressional trades found for CRMK or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRMKJNJ
Forward yield37037.04%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$2.4065325904961905e+22M$20.0K
Annual income after 10y$23,938,182,827,095,612,000,000,000,000.00$827.78
Total dividends collected$2.4056969570736264e+22M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRMK vs JNJ ($10,000, DRIP)

YearCRMK PortfolioCRMK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$3,714,404$3,703,703.70$10,676$355.77+$3.70MCRMK
2$1,289,680,090$1,285,705,677.99$11,407$389.39+$1289.67MCRMK
3$418,586,082,750$417,206,125,053.69$12,198$426.53+$418586.07MCRMK
4$127,000,083,643,664$126,552,196,535,121.55$13,056$467.62+$127000083.63MCRMK
5$36,020,244,067,789,990$35,884,353,978,291,260.00$13,987$513.12+$36020244067.78MCRMK
6$9,550,369,884,101,736,000$9,511,828,222,949,202,000.00$14,998$563.56+$9550369884101.72MCRMK
7$2,367,187,305,717,691,300,000$2,356,968,409,941,702,600,000.00$16,098$619.52+$2367187305717691.50MCRMK
8$548,520,032,501,626,100,000,000$545,987,142,084,508,200,000,000.00$17,295$681.69+$548520032501626112.00MCRMK
9$118,825,306,417,094,130,000,000,000$118,238,389,982,317,400,000,000,000.00$18,599$750.82+$118825306417094131712.00MCRMK
10$24,065,325,904,961,905,000,000,000,000$23,938,182,827,095,612,000,000,000,000.00$20,022$827.78+$2.4065325904961905e+22MCRMK

CRMK vs JNJ: Complete Analysis 2026

CRMKStock

Cermetek Microelectronics, Inc. designs, manufactures, and markets Internet appliance modems, modem components, and telephone line interfaces for the data communications industry. The company offers Internet connectivity devices, embedded device servers, high-speed modems, low-speed modems, modem modules, wireless data modules, embedded wireless devices, modules for wireless sensor networks, Internet protocol equipped modems, data access arrangements, and embedded Ethernet modules; and communications components for embedded communications. Its products are used in Internet appliance, embedded industrial, telecom, security/alarm, remote diagnostic and energy monitor, remote sensor, and conservation applications. The company sells its products to industrial OEMs through sales representatives and distributors in Australia/New Zealand, Mexico, France, Germany, Israel, Korea, Southeast Asia, Spain, Switzerland, Israel, North America, and Italy; and enables users to order online. Cermetek Microelectronics, Inc. was formerly known as Cermetek, Inc. The company was founded in 1968 and is based in Milpitas, California.

Full CRMK Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CRMK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRMK vs SCHDCRMK vs JEPICRMK vs OCRMK vs KOCRMK vs MAINCRMK vs ABBVCRMK vs MRKCRMK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.